Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 04 - 28 source : Www.biospace.com save search
Adaptimmune to Report Q1 2022 Financial Results and Business Updates on Monday, May 9, 2022
Published: 2022-04-28 (Crawled : 22:00) - biospace.com/
ADAP | $0.97 7.97% 7.38% 1.5M
|
Health Technology
|
| O: 0.0%
H: 1.14%
C: 0.0%
report results
Annovis Bio Announces Cooperative Research and Development Agreement (CRADA) with the National Institute on Aging
Published: 2022-04-28 (Crawled : 22:00) - biospace.com/
ANVS | $10.09 2.44% -0.15% 220K
|
Health Technology
|
| O: -0.89%
H: 4.1%
C: 0.9%
research
Histogen to Report First Quarter 2022 Financial Results and Provide Business Update
Published: 2022-04-28 (Crawled : 22:00) - biospace.com/
HSTO 1 d | $0.5 67.46% 530
|
Health Technology
|
| O: -0.25%
H: 4.86%
C: 1.64%
report results
Xencor to Host First Quarter 2022 Financial Results Webcast and Conference Call on May 5, 2022
Published: 2022-04-28 (Crawled : 22:00) - biospace.com/
XNCR | $18.385 -2.98% -3.07% 830K
|
Health Technology
|
| O: 1.17%
H: 0.0%
C: -2.54%
conference results
Aadi Bioscience to Announce First Quarter 2022 Financial Results on May 12, 2022
Published: 2022-04-28 (Crawled : 22:00) - biospace.com/
AADI | $1.835 1.94% 1.91% 140K
|
Manufacturing
|
| O: 2.2%
H: 0.0%
C: -2.4%
bioscience results
ClearPoint Neuro Announces FDA Clearance of the SmartFrame Array™ Version 1.1Next Generation Neuro Navigation System Designed for Use in Both the MRI Suite and Operating Room
Published: 2022-04-28 (Crawled : 22:00) - biospace.com/
CLPT | $5.35 -0.74% -0.75% 130K
|
Health Technology
|
| O: 1.53%
H: 3.68%
C: 2.55%
fda clearance system designation
Bio-Rad Reports First-Quarter 2022 Financial Results
Published: 2022-04-28 (Crawled : 22:00) - biospace.com/
BIO | $279.73 -0.46% 0.0% 290K
|
Health Technology
|
| O: 1.56%
H: 1.68%
C: 0.86%
results
Atara Biotherapeutics to Announce First Quarter 2022 Financial Results on Thursday, May 5, 2022
Published: 2022-04-28 (Crawled : 22:00) - biospace.com/
ATRA | $0.6755 -2.34% -2.4% 1.6M
|
Health Technology
|
| O: 2.57%
H: 1.47%
C: -0.88%
results
Sangamo Therapeutics Announces First Quarter 2022 Conference Call and Webcast
Published: 2022-04-28 (Crawled : 22:00) - biospace.com/
SGMO | $0.5143 6.02% 5.68% 1M
|
Health Technology
|
| O: 1.15%
H: 0.68%
C: -2.04%
conference therapeutics
Cytek Biosciences to Report First Quarter Financial Results on May 11, 2022
Published: 2022-04-28 (Crawled : 22:00) - biospace.com/
CTKB 4 | $5.92 -0.67% -0.68% 420K
|
Health Technology
|
| O: 1.09%
H: 4.43%
C: 4.21%
report cytek results
Omnicell Announces Financial Results for First Quarter 2022
Published: 2022-04-28 (Crawled : 22:00) - biospace.com/
OMCL | $27.86 2.24% 2.19% 330K
|
Technology Services
|
| O: 1.41%
H: 0.51%
C: -1.86%
Vanda Pharmaceuticals to Announce First Quarter 2022 Financial Results on May 5, 2022
Published: 2022-04-28 (Crawled : 22:00) - biospace.com/
VNDA | $5.11 2.82% 2.74% 2.4M
|
Health Technology
|
| O: 1.48%
H: 0.58%
C: -0.68%
results
Aerie Pharmaceuticals to Announce First Quarter 2022 Financial Results and Host Conference Call on Thursday, May 5, 2022 at 5:00 p.m. ET
Published: 2022-04-28 (Crawled : 22:00) - biospace.com/
AERI | $15.25 0.0%
|
Health Technology
|
| O: 1.63%
H: 0.52%
C: -1.2%
conference results
Oncocyte to Announce First Quarter 2022 Financial Results
Published: 2022-04-28 (Crawled : 22:00) - biospace.com/
OCX | News J | $2.495 -2.54% -2.61% 50K
|
Health Technology
|
| O: 0.0%
H: 0.88%
C: 0.0%
results
AbbVie Unites with Plexium to Leverage Protein Degraders Against Neurological Diseases
Published: 2022-04-28 (Crawled : 22:00) - biospace.com/
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.6%
H: 0.0%
C: 0.0%
neurological disease
Incyte and Maruho Announce Strategic Alliance Agreement for Ruxolitinib Cream in Japan
Published: 2022-04-28 (Crawled : 21:00) - biospace.com/
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 0.39%
H: 1.45%
C: 0.91%
japan
AbbVie Unites with Plexium to Leverage Protein Degradation Against Neurological Diseases
Published: 2022-04-28 (Crawled : 21:00) - biospace.com/
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.6%
H: 0.0%
C: 0.0%
neurological disease
Immutep to Announce New TACTI-002 Data in an Oral Presentation at the ASCO 2022 Annual Meeting
Published: 2022-04-28 (Crawled : 20:00) - biospace.com/
IMMP | $2.25 2.27% 2.22% 90K
|
Health Technology
|
| O: 0.91%
H: 11.27%
C: 8.6%
tacti-002 presentation asco
Madrigal Pharmaceuticals to Announce First Quarter 2022 Financial Results and Provide Clinical and Business Updates on May 9
Published: 2022-04-28 (Crawled : 20:00) - biospace.com/
MDGL | $212.33 -4.47% -4.68% 620K
|
Health Technology
|
| O: 1.88%
H: 0.1%
C: -2.37%
results
electroCore to Announce First Quarter 2022 Financial Results on May 5
Published: 2022-04-28 (Crawled : 20:00) - biospace.com/
ECOR | $6.0 6.38% 6.0% 7.4K
|
Health Technology
|
| O: 2.06%
H: 0.52%
C: -14.04%
results
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.